Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
about
Estrogen signaling in lung cancer: an opportunity for novel therapyTargeting the estrogen pathway for the treatment and prevention of lung cancerThe role of estrogen, progesterone and aromatase in human non-small-cell lung cancerInteraction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancerEnhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancerLigand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.Targeting the intracellular MUC1 C-terminal domain inhibits proliferation and estrogen receptor transcriptional activity in lung adenocarcinoma cells.Synchronous Multiple Lung Adenocarcinomas: Estrogen Concentration in Peripheral LungResearch resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancerPrevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens.Estrogen metabolism within the lung and its modulation by tobacco smoke.Prediagnosis soy food consumption and lung cancer survival in womenSoy food intake and risk of lung cancer: evidence from the Shanghai Women's Health Study and a meta-analysis.Association between the CYP11 family and six cancer types.Smoking out reproductive hormone actions in lung cancer.Estrongenic steroid hormones in lung cancer.Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada.Lung cancer in women: an overview with special focus on Spanish women.Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women.The Estrogen Receptor α-Cistrome Beyond Breast Cancer.Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells.Current status of research and treatment for non-small cell lung cancer in never-smoking females.Inhibition of non-small-cell lung cancer growth by combined fulvestrant and vandetanib.Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen.Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer.Estrogen, Estrogen Receptor and Lung CancerSmoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.[Recent Advances in Association of Estrogen and Non-small Cell Lung Cancer].[Advances in Association of Estrogen and Human Non-small Cell Lung Cancer].17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression.Second Primary Lung Cancer After Breast Cancer: A Population-Based Study of 6,269 WomenEstrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol
P2860
Q28385714-8D6856A6-BD82-48B1-8260-930865C66228Q28397456-C209BBF3-BE71-4030-8C83-9972F0F60FABQ28397662-60153FE1-7692-4C26-BFF3-54A568ED372AQ33648356-AF77A265-B081-4E7D-8A5B-5BAA4B8C22B9Q34526893-4B540155-7AA9-4089-8715-B64E47D71D72Q35338975-D4DB3A13-4DB7-4D63-A7E3-DCA8133D2014Q35541712-07671FC3-FC7E-4D62-B5EC-4DF2C5A58B4AQ36104207-46DA51D3-F233-45D4-B191-84FE149F3221Q36113804-9079E710-56A3-4FC1-8943-4D20A4A22C5CQ36612420-E59ACBE5-1123-4854-B09B-B7DC35278F0BQ36646986-AFCBAAF3-53C2-47C3-84EA-D58A258423AFQ36740713-24C13902-012E-4783-BDFF-5E8113A972AEQ36763839-ACAF59AC-10DD-44D8-AB95-D5FB2B4BFDDDQ36764972-B7DCD3DE-4BB5-411F-B68D-1F5D0C854AD7Q37001517-0AEBAA0B-4605-4511-AE53-019F08A80BB7Q37679479-65903C56-3505-49B3-9B7D-CA6EA18C6907Q37726987-40F4ACD0-B0CD-4139-94F5-107781B6C8CDQ38110168-C939397E-31BA-41CB-8E20-9BA27E43643AQ38166318-BF54B658-EB16-47D0-8016-EAF372FD8CD9Q38540913-DE80F280-AAD7-408A-B227-CA551EC4471DQ38917972-955C46F8-363A-4AFA-84CF-E0E799BE5C00Q38931802-CCD2724D-7FFA-44EF-ACED-92EF52AE8CEBQ39298725-D74B19AE-F0F6-4356-A788-95066268E4A8Q39610522-2FDFE409-7C4D-4748-80EB-BC352B37E758Q40383966-3AB28179-C26C-48D4-A054-8DA80D832A7DQ41346308-5223C544-B3B7-443E-BA5A-F5B3EFB4DA95Q41573792-D575AFF1-4833-476E-8BDC-5337C8489325Q47551685-7486EAAF-C227-45B3-AC91-F4391B2F4529Q47739563-2B839FAF-26CC-4A5D-91C3-1A0F11DB52D5Q50722910-2F59EB92-588C-4F7B-8E90-57EACE7F9555Q53731672-8C48C198-9B17-4A40-8EAF-92E61C7C78CFQ53843124-3AA27F53-422F-4DE5-A50D-A5A3B67CE068Q55517955-514FD9BB-5E2B-4931-80B1-9B4BCF56257DQ57816895-B167DC63-5976-4EB2-B7AA-A3DC4281D2C2Q58712246-CF8120FF-5FD4-425B-8BA7-EDBA8798C744
P2860
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
description
im Januar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 24 January 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@en
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@nl
type
label
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@en
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@nl
prefLabel
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@en
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@nl
P2093
P2860
P356
P1433
P1476
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
@en
P2093
Christine Bouchardy
Elisabetta Rapiti
Georges Vlastos
Gerald Fioretta
Helena M Verkooijen
Hyma Schubert
Jean-Charles Soria
Robin Schaffar
P2860
P304
P356
10.1002/CNCR.25638
P407
P577
2011-01-24T00:00:00Z